Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07179653
PHASE2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients
Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd.
View on ClinicalTrials.gov
Summary
The objective of this study was to evaluate the efficacy and safety of TVAX- 008 injection in a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II clinical trial in subjects with HBSAg levels of 0.05 to 100 IU/mL, including CHB patients previously treated with siRNA/ASO drugs and treatment-naive HBV infection.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2025-01-22
Completion Date
2026-12
Last Updated
2025-09-18
Healthy Volunteers
No
Conditions
Interventions
DRUG
TVAX-008
TVAX-008
DRUG
Placebo
Placebo
Locations (1)
NanFang Hospital
Guangzhou, Guangdong, China